celecoxib has been researched along with Pain, Chronic in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether respectively radial extracoporeal shock wave therapy (rESWT) or a combination of rESWT, celecoxib and eperisone (rESWT + C + E) are superior in reducing pain in patients with chronic nonspecific low back pain (cnsLBP) compared to C + E alone (a standard treatment of this condition in China)." | 9.41 | Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial. ( Feng, Z; Guo, X; Li, L; Li, Y; Peng, Z; Schmitz, C; Yan, Z; Yang, Y; Zhang, Y, 2021) |
| "The aim of this study was to examine the cost-effectiveness of branded and authorized generic (AG) celecoxib for chronic pain patients with osteoarthritis (OA), rheumatoid arthritis (RA), and low back pain (LBP), using real-world cost information for loxoprofen and pharmacotherapy for gastrointestinal bleeding." | 8.02 | Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan. ( Kamae, I; Karasawa, Y; Murata, T; Nozawa, K; Sakamoto, C; Soen, S; Zeniya, S, 2021) |
| "Pregabalin in the context of multimodal pain management may be associated with reduced opioid consumption and other medical complications in patients undergoing TKA, including previous users of chronic pain medications." | 7.80 | Pregabalin reduces opioid consumption and improves outcome in chronic pain patients undergoing total knee arthroplasty. ( Chen, AF; Hozack, WJ; Parvizi, J; Sawan, H; Viscusi, ER, 2014) |
| "In patients with chronic pain, oral analgesics are essential treatment options to manage pain appropriately, improve activities of daily living abilities and achieve a higher quality of life (QOL)." | 7.30 | Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee. ( Aono, H; Endo, M; Hara, T; Kawahara, S; Kawano, T; Mawatari, T; Miyaji, T; Miyake, M; Nakashima, Y; Sakamoto, S; Sato, T; Shimokawa, M; Takano, T; Tokunaga, M; Zenda, S, 2023) |
| "Chronic low back pain is a common clinical problem in both the human and canine population." | 6.87 | Intradiscal application of a PCLA-PEG-PCLA hydrogel loaded with celecoxib for the treatment of back pain in canines: What's in it for humans? ( Beukers, M; Bos, C; Creemers, LB; de Leeuw, M; Grinwis, GCM; Meij, BP; Plomp, SGM; Tellegen, AR; Tryfonidou, MA; van Dijk, M; Willems, N, 2018) |
| " There was no significant difference in the incidence of adverse events (AEs), SAEs, and discontinuations due to AEs; however, the incidence of gastrointestinal AEs in OA patients treatment with celecoxib is significantly higher than that with placebo." | 6.53 | Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. ( Gu, K; Hou, Y; Xu, C; Yasen, Y, 2016) |
| "Tramadol-acetaminophen was effective at reducing chronic LBP and conferred a prophylactic motivational effect in patients with chronic LBP." | 5.43 | Effect of Tramadol/Acetaminophen on Motivation in Patients with Chronic Low Back Pain. ( Nishida, K; Ozaki, T; Takei, Y; Tanaka, M; Tetsunaga, T, 2016) |
| "To investigate whether respectively radial extracoporeal shock wave therapy (rESWT) or a combination of rESWT, celecoxib and eperisone (rESWT + C + E) are superior in reducing pain in patients with chronic nonspecific low back pain (cnsLBP) compared to C + E alone (a standard treatment of this condition in China)." | 5.41 | Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial. ( Feng, Z; Guo, X; Li, L; Li, Y; Peng, Z; Schmitz, C; Yan, Z; Yang, Y; Zhang, Y, 2021) |
| "Celecoxib is frequently prescribed to treat knee osteoarthritis (KOA), but how celecoxib influences the activity of the central nervous system to alleviate chronic pain remains unclear." | 5.30 | Cerebral mechanism of celecoxib for treating knee pain: study protocol for a randomized controlled parallel trial. ( Chen, Y; Cheng, S; Dong, X; He, W; Huang, Y; Li, Z; Liang, F; Sheng, Y; Tang, C; Wu, X; Yin, B; Zeng, F; Zhou, J, 2019) |
| "We know from adult randomised controlled trials that some NSAIDs, such as ibuprofen, naproxen, and aspirin, can be effective in certain chronic pain conditions." | 4.95 | Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents. ( Anderson, B; Cooper, TE; Eccleston, C; Fisher, E; Wilkinson, NM, 2017) |
| "The aim of this study was to examine the cost-effectiveness of branded and authorized generic (AG) celecoxib for chronic pain patients with osteoarthritis (OA), rheumatoid arthritis (RA), and low back pain (LBP), using real-world cost information for loxoprofen and pharmacotherapy for gastrointestinal bleeding." | 4.02 | Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan. ( Kamae, I; Karasawa, Y; Murata, T; Nozawa, K; Sakamoto, C; Soen, S; Zeniya, S, 2021) |
| " Pelvic pain had developed in EAP rats, which was attenuated by a single treatment with celecoxib or pregabalin, suggesting that EAP is an appropriate model for prostatitis-related pain." | 3.88 | Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain. ( Kotera, T; Kurita, M; Oka, M; Okamoto, K; Yamaguchi, H, 2018) |
| "Pregabalin in the context of multimodal pain management may be associated with reduced opioid consumption and other medical complications in patients undergoing TKA, including previous users of chronic pain medications." | 3.80 | Pregabalin reduces opioid consumption and improves outcome in chronic pain patients undergoing total knee arthroplasty. ( Chen, AF; Hozack, WJ; Parvizi, J; Sawan, H; Viscusi, ER, 2014) |
| "In patients with chronic pain, oral analgesics are essential treatment options to manage pain appropriately, improve activities of daily living abilities and achieve a higher quality of life (QOL)." | 3.30 | Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee. ( Aono, H; Endo, M; Hara, T; Kawahara, S; Kawano, T; Mawatari, T; Miyaji, T; Miyake, M; Nakashima, Y; Sakamoto, S; Sato, T; Shimokawa, M; Takano, T; Tokunaga, M; Zenda, S, 2023) |
| "Chronic low back pain is a common clinical problem in both the human and canine population." | 2.87 | Intradiscal application of a PCLA-PEG-PCLA hydrogel loaded with celecoxib for the treatment of back pain in canines: What's in it for humans? ( Beukers, M; Bos, C; Creemers, LB; de Leeuw, M; Grinwis, GCM; Meij, BP; Plomp, SGM; Tellegen, AR; Tryfonidou, MA; van Dijk, M; Willems, N, 2018) |
| "Chronic pain is associated with impaired regulation of cardiovascular and analgesia systems, which may predispose to persistent BP elevation." | 2.82 | The Effects of Pain and Analgesic Medications on Blood Pressure. ( Coscarelli, A; Giordano, A; Menale, S; Rivasi, G; Turrin, G; Ungar, A, 2022) |
| " There was no significant difference in the incidence of adverse events (AEs), SAEs, and discontinuations due to AEs; however, the incidence of gastrointestinal AEs in OA patients treatment with celecoxib is significantly higher than that with placebo." | 2.53 | Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. ( Gu, K; Hou, Y; Xu, C; Yasen, Y, 2016) |
| " For older adult patients at higher risk for NSAID-related adverse effects, such as those who have gastrointestinal or cardiovascular disease, diabetes mellitus, or who are taking low-dose aspirin, opioids are recommended instead." | 2.49 | Opioids for chronic pain: new evidence, new strategies, safe prescribing. ( de Leon-Casasola, OA, 2013) |
| "Tramadol-acetaminophen was effective at reducing chronic LBP and conferred a prophylactic motivational effect in patients with chronic LBP." | 1.43 | Effect of Tramadol/Acetaminophen on Motivation in Patients with Chronic Low Back Pain. ( Nishida, K; Ozaki, T; Takei, Y; Tanaka, M; Tetsunaga, T, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 6 (31.58) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X | 1 |
| Li, L | 1 |
| Yan, Z | 1 |
| Li, Y | 2 |
| Peng, Z | 1 |
| Yang, Y | 1 |
| Zhang, Y | 1 |
| Schmitz, C | 1 |
| Feng, Z | 1 |
| Rivasi, G | 1 |
| Menale, S | 1 |
| Turrin, G | 1 |
| Coscarelli, A | 1 |
| Giordano, A | 1 |
| Ungar, A | 1 |
| Xu, H | 1 |
| Zhao, C | 1 |
| Guo, G | 1 |
| A, X | 1 |
| Qiu, G | 1 |
| Wang, Y | 1 |
| Kang, B | 1 |
| Xu, X | 1 |
| Xie, J | 1 |
| Xiao, L | 1 |
| Antonen, EG | 1 |
| Kruchek, MM | 1 |
| Nikitina, MV | 1 |
| Endo, M | 1 |
| Kawahara, S | 1 |
| Sato, T | 1 |
| Tokunaga, M | 1 |
| Hara, T | 1 |
| Mawatari, T | 1 |
| Kawano, T | 1 |
| Zenda, S | 1 |
| Miyaji, T | 1 |
| Shimokawa, M | 1 |
| Sakamoto, S | 1 |
| Takano, T | 1 |
| Miyake, M | 1 |
| Aono, H | 1 |
| Nakashima, Y | 1 |
| Karasawa, Y | 1 |
| Kamae, I | 1 |
| Nozawa, K | 1 |
| Zeniya, S | 1 |
| Murata, T | 1 |
| Soen, S | 1 |
| Sakamoto, C | 1 |
| Tellegen, AR | 1 |
| Willems, N | 1 |
| Beukers, M | 1 |
| Grinwis, GCM | 1 |
| Plomp, SGM | 1 |
| Bos, C | 1 |
| van Dijk, M | 1 |
| de Leeuw, M | 1 |
| Creemers, LB | 1 |
| Tryfonidou, MA | 1 |
| Meij, BP | 1 |
| Eccleston, C | 1 |
| Cooper, TE | 1 |
| Fisher, E | 1 |
| Anderson, B | 1 |
| Wilkinson, NM | 1 |
| Kurita, M | 1 |
| Yamaguchi, H | 1 |
| Okamoto, K | 1 |
| Kotera, T | 1 |
| Oka, M | 1 |
| Tang, C | 1 |
| Dong, X | 1 |
| He, W | 1 |
| Cheng, S | 1 |
| Chen, Y | 1 |
| Huang, Y | 1 |
| Yin, B | 1 |
| Sheng, Y | 1 |
| Zhou, J | 1 |
| Wu, X | 1 |
| Zeng, F | 1 |
| Li, Z | 1 |
| Liang, F | 1 |
| Lee, JY | 2 |
| Choi, HY | 1 |
| Park, CS | 1 |
| Jang, C | 1 |
| Lee, KT | 1 |
| Youn, I | 1 |
| Yune, TY | 1 |
| de Leon-Casasola, OA | 1 |
| Sawan, H | 1 |
| Chen, AF | 1 |
| Viscusi, ER | 1 |
| Parvizi, J | 1 |
| Hozack, WJ | 1 |
| Danilov, AB | 1 |
| Grigorenko, NV | 1 |
| Laux-Biehlmann, A | 1 |
| Boyken, J | 1 |
| Dahllöf, H | 1 |
| Schmidt, N | 1 |
| Zollner, TM | 1 |
| Nagel, J | 1 |
| Xu, C | 1 |
| Gu, K | 1 |
| Yasen, Y | 1 |
| Hou, Y | 1 |
| Tetsunaga, T | 2 |
| Tanaka, M | 1 |
| Nishida, K | 1 |
| Takei, Y | 1 |
| Ozaki, T | 1 |
| Rastogi, R | 1 |
| Swarm, RA | 1 |
| Patel, TA | 1 |
| Robinson, I | 1 |
| Sargent, B | 1 |
| Hatcher, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Randomized, Controlled, Single Centre Trial to Assess the Efficacy and Safety of Radial Extracorporeal Shock Wave Therapy in Patients With Chronic Non-specific Low Back Pain[NCT03337607] | 150 participants (Anticipated) | Interventional | 2017-11-13 | Recruiting | |||
| Comparative Effects of Shockwave Therapy and Maitland's Lumbar Mobilization on Pain, Disability and Range of Motion in Patients With Mechanical Low Back Pain[NCT05404997] | 26 participants (Anticipated) | Interventional | 2022-03-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for celecoxib and Pain, Chronic
| Article | Year |
|---|---|
The Effects of Pain and Analgesic Medications on Blood Pressure.
Topics: Acetaminophen; Adrenergic Agents; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Ster | 2022 |
Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Arthritis, Rheumatoid; Asp | 2017 |
Opioids for chronic pain: new evidence, new strategies, safe prescribing.
Topics: Age Factors; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Pain; C | 2013 |
[An antinociceptive effect of chondroprotectors: a myth or a reality?].
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Celecoxib; Chondroitin Sulf | 2015 |
Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials.
Topics: Abdominal Pain; Celecoxib; Chronic Pain; Cyclooxygenase 2 Inhibitors; Diarrhea; Dyspepsia; Headache; | 2016 |
Case scenario: opioid association with serotonin syndrome: implications to the practitioners.
Topics: Analgesics, Opioid; Antidepressive Agents, Tricyclic; Celecoxib; Chronic Pain; Cyclooxygenase 2 Inhi | 2011 |
5 trials available for celecoxib and Pain, Chronic
8 other studies available for celecoxib and Pain, Chronic
| Article | Year |
|---|---|
[Evaluation of the effectiveness of treatment of patients with nonspecific pain syndrome in the lower back with celecoxib and a combined preparation of B vitamins].
Topics: Adult; Celecoxib; Chronic Pain; Female; Humans; Low Back Pain; Male; Meloxicam; Middle Aged; Pain Me | 2022 |
Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan.
Topics: Aged; Aged, 80 and over; Celecoxib; Chronic Pain; Computer Simulation; Cost Savings; Cost-Benefit An | 2021 |
Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain.
Topics: Analgesics; Animals; Autoimmune Diseases; Celecoxib; Chemokines; Chronic Pain; Cytokines; Disease Mo | 2018 |
Inhibition of COX-2 alleviates lumbar spinal stenosis-induced chronic mechanical allodynia in rats.
Topics: Animals; Cauda Equina; Celecoxib; Chronic Pain; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytok | 2019 |
Pregabalin reduces opioid consumption and improves outcome in chronic pain patients undergoing total knee arthroplasty.
Topics: Acetaminophen; Aged; Analgesics; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Celecoxib; Chr | 2014 |
Dynamic weight bearing as a non-reflexive method for the measurement of abdominal pain in mice.
Topics: Abdominal Pain; Aniline Compounds; Animals; Behavior, Animal; Celecoxib; Chronic Pain; Cyclooxygenas | 2016 |
Effect of Tramadol/Acetaminophen on Motivation in Patients with Chronic Low Back Pain.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Apathy; | 2016 |
Use of dynamic weight bearing as a novel end-point for the assessment of Freund's Complete Adjuvant induced hypersensitivity in mice.
Topics: Adjuvants, Immunologic; Animals; Celecoxib; Chronic Pain; Cyclooxygenase 2 Inhibitors; Endpoint Dete | 2012 |